跨区域注册对标 / Cross-Region Benchmark
Companies and products registered in multiple regions (CDE + DMF + CEP)
Cross-Region Companies
681
CDE+DMF+CEP Triple
240
CDE+DMF Dual
542
CDE+CEP Dual
315
Cross-Region Products
1047 total, page 1 of 53| Product | CAS | CDE | DMF | CEP | Pattern | Action |
|---|---|---|---|---|---|---|
| Rivaroxaban 利伐沙班 | 366789-02-8 | 52 | 23 | 8 | CDE+DMF+CEP | View → |
| Tadalafil 他达拉非 | 171596-29-5 | 67 | 9 | 6 | CDE+DMF+CEP | View → |
| Ticagrelor 替格瑞洛 | 274693-27-5 | 40 | 19 | 11 | CDE+DMF+CEP | View → |
| Atorvastatin Calcium 阿托伐他汀钙 | 134523-00-5 | 49 | 9 | 7 | CDE+DMF+CEP | View → |
| Celecoxib 塞来昔布 | 169590-42-5 | 47 | 6 | 8 | CDE+DMF+CEP | View → |
| Esomeprazole Sodium 埃索美拉唑镁 | 119141-88-7 | 54 | 4 | 2 | CDE+DMF+CEP | View → |
| Lansoprazole 兰索拉唑 | 103577-45-3 | 49 | 4 | 2 | CDE+DMF+CEP | View → |
| Telmisartan 替米沙坦 | 144701-48-4 | 41 | 6 | 5 | CDE+DMF+CEP | View → |
| Rosuvastatin Calcium 瑞舒伐他汀钙 | 287714-41-4 | 31 | 13 | 7 | CDE+DMF+CEP | View → |
| Brivaracetam 布瓦西坦 | 357336-20-0 | 30 | 16 | 3 | CDE+DMF+CEP | View → |
| Ofloxacin 氧氟沙星 | 82419-36-1 | 43 | 2 | 1 | CDE+DMF+CEP | View → |
| Capecitabine 卡培他滨 | 154361-50-9 | 35 | 7 | 4 | CDE+DMF+CEP | View → |
| Levetiracetam 左乙拉西坦 | 102767-28-2 | 29 | 9 | 7 | CDE+DMF+CEP | View → |
| Lidocaine 利多卡因 | 137-58-6 | 39 | 4 | 1 | CDE+DMF+CEP | View → |
| Pregabalin 普瑞巴林 | 148553-50-8 | 29 | 11 | 4 | CDE+DMF+CEP | View → |
| Olmesartan Medoxomil 奥美沙坦酯 | 144689-63-4 | 31 | 4 | 6 | CDE+DMF+CEP | View → |
| Docetaxel 多西他赛 | 114977-28-5 | 28 | 8 | 5 | CDE+DMF+CEP | View → |
| Mannitol 甘露醇 | 69-65-8 | 30 | 10 | 1 | CDE+DMF+CEP | View → |
| Chondroitin Sulfate Sodium 硫酸软骨素钠 | 55871-03-9 | 20 | 16 | 4 | CDE+DMF+CEP | View → |
| Paclitaxel 紫杉醇 | 33069-62-4 | 25 | 14 | 1 | CDE+DMF+CEP | View → |